Underlying Chart

2162 KEYMED BIO-B

Price(HKD)	Change (%)	Bid	Ask	Turnover ($K)
52.600	-1.55(-2.86%)	52.550	52.600	65,593.60

Price(HKD)	52.600
Change (%)	-1.55(-2.86%)
Bid	52.550
Ask	52.600
Turnover ($K)	65,593.60

Last update time: 13/03/2026 16:20 (15 minutes delayed)

KEYMED BIO-BMoney Inflow/Outflow Report

Last update time:

2162 KEYMED BIO-B (- to -)

Candle Chart

Bar Chart

Line Chart

 Zoom In

 Zoom Out

Moving Average

10days

20days

50days

100days

250days

Sub Chart1

RSI
MACD Len1	Len2	Len3
WPR %R
DMI
MOM

Bollinger

Sub Chart2

RSI
MACD Len1	Len2	Len3
WPR %R
DMI
MOM

Submit Reset

Related Chart

Code	Underlying	Type	Maturity Date(D/M/Y)	Strike	Price(HKD)	Change(%)	Premium(%)	Effective Gearing(X)	Implied Volatility(%)	Conversion Ratio	Outstanding Qty(M)	Turnover($K)
No Related Data

Code	Underlying	Type	Maturity Date(D/M/Y)	Strike	Price(HKD)	Change(%)	Premium(%)	Effective Gearing(X)	Implied Volatility(%)	Conversion Ratio	Outstanding Qty(M)	Turnover($K)
No Related Data

Code	Underlying	Type	Maturity Date (D/M/Y)	Strike	Call Level	Price(HKD)	Change(%)	Premium(%)	Gearing(X)	Conversion Ratio	Outstanding Qty(M)	Turnover($K)
No Related Data

Code	Underlying	Type	Maturity Date (D/M/Y)	Strike	Call Level	Price(HKD)	Change(%)	Premium(%)	Gearing(X)	Conversion Ratio	Outstanding Qty(M)	Turnover($K)
No Related Data

Back To Top

All data are at least 15 mins delayed

Information Provided by DB Power Online Limited [ Disclaimer ]

Disclaimer and Important Note:
This information is provided by BOCI Asia Limited, a licensed corporation with the Securities and Futures Commission of Hong Kong （“SFC”）. The content of this website has not been approved by the SFC. Any materials provided on this website are provided for reference only and does not constitute an offer, a solicitation of an offer or any advice or recommendation to conclude or participate in any transaction, or provide any investment advice or service. Past performance is not indicative of future performance. The price of structured products such as Warrant, CBBC and/or Inline Warrant may go down as well as up and the value of which may become worthless before the expiry date, as such, investors may sustain a total loss of investment. Please note that CBBC have a mandatory call feature and may therefore be subject to early termination, upon which （i）investors in category N CBBC will lose all their investments in CBBC; and （ii）the residual value of category R CBBCs may be zero. Please also note that Inline Warrant is newly introduced to the market and there is no similar products currently listed on the Exchange for comparison. In addition, structured products issued by BOCI Asia Limited or its affiliate are uncollateralised and investors are relying on the issuer’s credit worthiness in determining the issuer’s ability to meet its obligations under the structured products. This is a non-collateralised product. If the Issuer is insolvent or defaults, investors may not recover part or all of the amount due. An investor should read carefully the relevant listing documents （and any documents appendix thereto）and the relevant supplemental listing document to understand the full details of the Warrant, CBBC and/or Inline Warrant（including risk factors provided therein）, and due consideration have been given having considered the nature and risks involved in investing in these products, to decide whether the investment is suitable for an investor’s individual circumstances and, if necessary, an investor should consult their professional advisers. BOCI Securities Limited is the liquidity provider for the Warrant, CBBC and/or Inline Warrant issued by BOCI Asia Limited and may be the only person quoting prices for the Warrant, CBBC and/or Inline Warrant issued by BOCI Asia Limited. BOCI Asia Limited, BOCI Securities Limited and its affiliated companies do not make any representations or warranties as to the liquidity of the Warrant, CBBC and/or Inline Warrant. BOCI Asia Limited or its affiliates （“BOCI Group”） provides the information in good faith to ensure that the information provided is accurate and reliable. BOCI Group does not represent or warrant the completeness, reliability and accuracy of the information and BOCI Group does not accept any responsibility for any inaccuracies or omissions of the information.

Treatment of Personal Data Privacy Statement
Thank you for your interest in our services and products. Your privacy is important to us and we want you to feel comfortable visiting our website. We take care to protect your personal data collected, processed and used during visits to the BOCI website.

By accessing BOCI website you accept this privacy statement.
If you do not agree to this statement, do not proceed to further web pages of the BOCI website.

How may your personal data be used?
Your personal data may be used only for the purposes of （i） technical administration （ii） research & development of financial services or related products （iii） customer and user administration and （iv）marketing. We use your personal data to inform you about our services and products only in line with applicable laws and regulations. Your personal data will be used for compliance and regulatory purposes.

How do we collect and store information from you?
You are informed that when visits are made to this Website, cookies may be installed automatically and retained temporarily in your memory or on your hard disk. Cookies will record information about your use of this Website. You acknowledge that you have been informed of this practice and authorize BOCI to use any information collected through our use of cookies in connection with the purposes set out under “How may your personal data be used?” above. You may deactivate the cookies in the settings of your navigation software. If you choose not to accept cookies, you can still visit the BOCI website. However, this may result in a reduced availability of the services provided by BOCI website.

To whom do we disclose information gathered from the BOCI website?
BOCI may disclose your information to it and its affiliates’ employees, agents and third party service providers. We may also disclose your information to governmental agencies and regulatory authorities having jurisdiction over our business affairs. We will procure that the foregoing recipients of your information to observe personal data privacy.

We will make available the listing documents and announcements in printed form during usual business hours on any weekday (Saturdays, Sundays and holidays excepted) at BOCI Asia Limited, 20/F, Bank of China Tower, 1 Garden Road, Hong Kong to holders of our listed structured products free of charge upon request.

Disclaimer and Important Note

Disclaimer and Important Note:
This information is provided by BOCI Asia Limited, a licensed corporation with the Securities and Futures Commission of Hong Kong （“SFC”）. The content of this website has not been approved by the SFC. Any materials provided on this website are provided for reference only and does not constitute an offer, a solicitation of an offer or any advice or recommendation to conclude or participate in any transaction, or provide any investment advice or service. Past performance is not indicative of future performance. The price of structured products such as Warrant, CBBC and/or Inline Warrant may go down as well as up and the value of which may become worthless before the expiry date, as such, investors may sustain a total loss of investment. Please note that CBBC have a mandatory call feature and may therefore be subject to early termination, upon which （i）investors in category N CBBC will lose all their investments in CBBC; and （ii）the residual value of category R CBBCs may be zero. Please also note that Inline Warrant is newly introduced to the market and there is no similar products currently listed on the Exchange for comparison. In addition, structured products issued by BOCI Asia Limited or its affiliate are uncollateralised and investors are relying on the issuer’s credit worthiness in determining the issuer’s ability to meet its obligations under the structured products. This is a non-collateralised product. If the Issuer is insolvent or defaults, investors may not recover part or all of the amount due. An investor should read carefully the relevant listing documents （and any documents appendix thereto）and the relevant supplemental listing document to understand the full details of the Warrant, CBBC and/or Inline Warrant（including risk factors provided therein）, and due consideration have been given having considered the nature and risks involved in investing in these products, to decide whether the investment is suitable for an investor’s individual circumstances and, if necessary, an investor should consult their professional advisers. BOCI Securities Limited is the liquidity provider for the Warrant, CBBC and/or Inline Warrant issued by BOCI Asia Limited and may be the only person quoting prices for the Warrant, CBBC and/or Inline Warrant issued by BOCI Asia Limited. BOCI Asia Limited, BOCI Securities Limited and its affiliated companies do not make any representations or warranties as to the liquidity of the Warrant, CBBC and/or Inline Warrant. BOCI Asia Limited or its affiliates （“BOCI Group”） provides the information in good faith to ensure that the information provided is accurate and reliable. BOCI Group does not represent or warrant the completeness, reliability and accuracy of the information and BOCI Group does not accept any responsibility for any inaccuracies or omissions of the information.

Treatment of Personal Data Privacy Statement
Thank you for your interest in our services and products. Your privacy is important to us and we want you to feel comfortable visiting our website. We take care to protect your personal data collected, processed and used during visits to the BOCI website.

By accessing BOCI website you accept this privacy statement.
If you do not agree to this statement, do not proceed to further web pages of the BOCI website.

How may your personal data be used?
Your personal data may be used only for the purposes of （i） technical administration （ii） research & development of financial services or related products （iii） customer and user administration and （iv）marketing. We use your personal data to inform you about our services and products only in line with applicable laws and regulations. Your personal data will be used for compliance and regulatory purposes.

How do we collect and store information from you?
You are informed that when visits are made to this Website, cookies may be installed automatically and retained temporarily in your memory or on your hard disk. Cookies will record information about your use of this Website. You acknowledge that you have been informed of this practice and authorize BOCI to use any information collected through our use of cookies in connection with the purposes set out under “How may your personal data be used?” above. You may deactivate the cookies in the settings of your navigation software. If you choose not to accept cookies, you can still visit the BOCI website. However, this may result in a reduced availability of the services provided by BOCI website.

To whom do we disclose information gathered from the BOCI website?
BOCI may disclose your information to it and its affiliates’ employees, agents and third party service providers. We may also disclose your information to governmental agencies and regulatory authorities having jurisdiction over our business affairs. We will procure that the foregoing recipients of your information to observe personal data privacy.

We will make available the listing documents and announcements in printed form during usual business hours on any weekday (Saturdays, Sundays and holidays excepted) at BOCI Asia Limited, 20/F, Bank of China Tower, 1 Garden Road, Hong Kong to holders of our listed structured products free of charge upon request.

Underlying Chart $(document).ready(function () { $("#searchbox").keyup(function(e) { var scode = $.trim($("#searchbox").val()); if(e.keyCode == 13 && scode != "") { gokeysearch(); } }); $("#searchbox").click(function(){ $("#searchbox").val(""); }); });

KEYMED BIO-BMoney Inflow/Outflow Report

2162 KEYMED BIO-B (- to -)

Underlying Chart